Precision Tests for Oncology

OncoAssure is a medical diagnostics company that identifies, develops, and commercialises clinically important biomarkers to significantly improve cancer management and treatment.

 
 

OncoAssure Molecular Diagnostics

Our lead product is a post-biopsy test for prostate cancer that measures the expression of genes that are key drivers of cancer progression.

 
 
Cancer-Test-Kit-for-Results.jpg
 
 

The OncoAssure Process

OncoAssure aims to meet the most critical clinical needs by combining the latest transcriptomic and mathematical modelling techniques followed by stringent analytical and clinical validation.

 

Our Expertise in Oncology Molecular Diagnostics

The OncoAssure team have the key skills, expertise, and a proven track record in identifying, developing, and commercialising cancer biomarkers.

 

Our Partners